1 – 10 of 155
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
TREM2 risk variants and associated endophenotypes in alzheimer’s disease
- Contribution to journal › Article
-
Mark
Amyloid-β deposition predicts oscillatory slowing of magnetoencephalography signals and a reduction of functional connectivity over time in cognitively unimpaired adults
- Contribution to journal › Article
-
Mark
Neuronal CD59 isoforms IRIS-1 and IRIS-2 as regulators of neurotransmitter release with implications for Alzheimer’s disease
- Contribution to journal › Article
-
Mark
evoke and evoke+ : design of two large-scale, double-blind, placebo-controlled, phase 3 studies evaluating efficacy, safety, and tolerability of semaglutide in early-stage symptomatic Alzheimer’s disease
- Contribution to journal › Article
-
Mark
Benchmarking Alzheimer’s disease prediction : personalised risk assessment using polygenic risk scores across various methodologies and genome-wide studies
- Contribution to journal › Article
-
Mark
Exploring the thermodynamic and kinetic landscape of amyloid fibril formation
(2025)
- Thesis › Doctoral thesis (compilation)
-
Mark
Strong diagnostic performance of plasma ptau217 for CSF biomarker-defined young-onset Alzheimer disease in a diagnostically heterogeneous clinical cohort
- Contribution to journal › Article
-
Mark
Differential effects of aging, Alzheimer's pathology, and APOE4 on longitudinal functional connectivity and episodic memory in older adults
- Contribution to journal › Article
-
Mark
Evaluating the Bidirectional Causal Effects of Alzheimer’s Disease Across Multiple Conditions : A Systematic Review and Meta-Analysis of Mendelian Randomization Studies
- Contribution to journal › Scientific review
-
Mark
Comparison of plasma ALZpath p-Tau217 with Lilly p-Tau217 and p-Tau181 in a neuropathological cohort
- Contribution to journal › Article
